Forte Biosciences Inc (FBRX) — Strategic Asset Allocation Index
Forte Biosciences Inc (FBRX) has a Strategic Asset Allocation Index of 0.1% as of June 2021. Strategic assets (PP&E of $70.00K plus long-term investments of $-) total $70.00K, measured against net assets of $49.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Forte Biosciences Inc (FBRX) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Forte Biosciences Inc Strategic Asset Allocation Index (2015–2020)
This chart shows how Forte Biosciences Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2015 to 2020. As of June 2021, the index stands at 0.1%, representing strategic assets of $70.00K against net assets of $49.91 Million USD. For live market cap and overall valuation, see FBRX market cap overview.
Annual Strategic Asset Allocation Index for Forte Biosciences Inc (2015–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Forte Biosciences Inc from 2015 to 2020, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See FBRX net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 0.2% | $97.00K | $97.00K | $- | $58.98 Million | ▼ -2.5 pp |
| 2019 | 2.6% | $152.00K | $152.00K | $- | $5.75 Million | ▼ -4.2 pp |
| 2018 | 6.8% | $3.97 Million | $3.97 Million | $- | $58.15 Million | ▲ +5.1 pp |
| 2017 | 1.7% | $1.22 Million | $1.22 Million | $- | $71.08 Million | ▼ -8.9 pp |
| 2016 | 10.6% | $743.00K | $743.00K | $- | $7.00 Million | ▲ +9.5 pp |
| 2015 | 1.1% | $445.00K | $445.00K | $- | $39.08 Million | — |